CClinicalTrials.gg
Status unknownNCT05277805Updated Mar 30, 2023

The Development and Validation of EMPOWER-UP: a Generic Questionnaire for Measuring Empowerment in Patient-provider Relationships

An observational study in Cancer, Diabetes and Mental Disorder, sponsored by Rigshospitalet, Denmark. Status unknown at 3 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-30.

Sponsored by Rigshospitalet, Denmark · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
526
Ages
18 Years and older
Sex
All
01

Study summary

Empowerment is widely acknowledged as an important approach in long-term care. The concept relates to the individual's ability to manage their own life and make rational decisions. Despite good intentions of working empowerment-based, research has shown that it can be difficult to realize and achieve in everyday practice within the healthcare system. To this date, no measurement instrument (questionnaire) exists that evaluate people's perceptions of whether their relationship with a healthcare provider promotes their empowerment process. The EMPOWER-UP questionnaire was therefore developed to provide such a measure. The EMPOWER-UP study aims to finalize the development process of the questionnaire and to test whether it is a valid and reliable measure.

People at the age of 18 years or above can participate if they have ever been diagnosed with a type of cancer, diabetes, or a mental illness and because of that diagnosis have been in contact with the healthcare system within the past six months.

The study is conducted online and requires participants to fill out an online questionnaire on a single occasion. Participation is expected to take no more than 10-15 minutes.

By participating, people may experience an increased awareness as to the nature of their interactions with healthcare providers. For some, this awareness may be beneficial and may alone enable them to ask for better care, while others may experience it as a burden if they are not able to seek better care.

By participating, people are helping to ensure that EMPOWER-UP will be a good questionnaire that may help raise awareness of the quality of relationships within the healthcare system and in term lead to better care.

The study is led by a team of researchers at the Danish University Hospital Rigshospitalet and the University of Copenhagen, Denmark.

The UK lead of the study is located at King's College London, UK. The Australian lead of the study is located at Deakin University, Melbourne, Australia.

This study is financially supported by the Novo Nordisk Foundation's Steno Collaborative Grant and by the Trygfonden foundation (Denmark)

02

Conditions studied

  • Cancer
  • Diabetes
  • Mental Disorder

Browse trials for

03

In context

Mental Disorders

2,109 studies on the registry are indexed under Mental Disorders; 417 are open to participants now.

This study's enrollment of 526 is above the median of 200 across 480 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People are invited to participate through patient organizations, disease-specific patient boards, general care clinics, and outpatient clinics at hospitals in Denmark, the UK, and Australia

Inclusion criteria

  • Ever diagnosed with cancer, diabetes, or a mental disorder AND have had an interaction with a healthcare provider concerning their cancer/diabetes/mental disorder diagnosis within the past six months (relating to e.g. treatment or follow-up consultations)

Exclusion criteria

Exclusion Criteria:

  • Unable to read and understand Danish (for danish participants) or English (for UK and australian participants)
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
526 participants (actual)
Patient registry
No

Groups and cohorts

  • EMPOWER-UP participants

    People with cancer, diabetes, or mental disorders answering the EMPOWER-UP questionnaire

    Other: EMPOWER-UP questionnaire

Interventions

  • OtherEMPOWER-UP questionnaire

    Participants are asked to respond to the EMPOWER-UP questionnaire to test the psychometric properties of the questionnaire.

06

What researchers measure

Primary outcomes

  1. Relational empowerment

    EMPOWER-UP questionnaire

    Time frame: Baseline

07

Study locations

3 sites
  • Deakin University, Online
    Melbourne, Australia
  • Rigshospitalet, online
    Copenhagen, Denmark
  • King's College London, online
    London, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05277805
Lead sponsor
Rigshospitalet, Denmark
Collaborators
King's College London, Deakin University
Responsible party
Emilie Haarslev Schröder Marqvorsen (Ph.d. student, MSc, Rigshospitalet, Denmark) — Principal investigator
First posted
Mar 14, 2022
Start date
Jan 1, 2020
Primary completion
Oct 11, 2022
Completion
Aug 23, 2023 (estimated)
Last update
Mar 30, 2023

Study contacts

Vibeke Zoffmann, Professor
study chair · Rigshospitalet, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion